Tax

SECURE Energy Services Inc. in its $300-million high-yield note offering

On March 19, 2024, Osler acted for a syndicate of underwriters, led by BMO Capital Markets and National Bank Financial Markets as joint bookrunners, in connection with SECURE Energy Services Inc.’s $300-million private placement offering of 6.750% senior unsecured notes due 2029.   Osler,...

Lead Office: Toronto Date Announced: Mar 19, 2024 Value: $300 million

Fusion Pharmaceuticals in its acquisition by AstraZeneca

On March 19, 2024, Fusion Pharmaceuticals announced that it entered into a definitive agreement to be acquired by AstraZeneca for a transaction value of approximately US$2.4 billion. Through this acquisition, AstraZeneca is taking a significant leap towards its goal of revolutionizing cancer...

Lead Office: Toronto Date Closed: -- Value: US$2.4 billion

Verndale in its acquisition of Yaksa

On March 18, 2024, Verndale announced its acquisition of Yaksa, a digital commerce experience agency that focuses on B2B and B2C ecommerce websites and enterprise content websites. Through this acquisition, Verndale aims to enhance its market presence and strengthen its product offerings for...

Lead Office: Montreal Date Closed: March 18, 2024 Value: -

Mind Medicine in its US$175 million underwritten public offering and concurrent private placement

Osler represented Mind Medicine (MindMed) Inc. as Canadian counsel in connection with its US$175 million underwritten public offering and concurrent private placement. Leerink Partners and Cantor acted as joint bookrunning managers for the underwritten offering and placement agents for the...

Lead Office: Vancouver Date Announced: Mar 14, 2024 Value: US$175 million

Frontier Lithium Inc. in its Joint Venture with Mitsubishi Corporation to develop the PAK Lithium Project

On March 4, 2024, Frontier Lithium Inc. announced its definitive agreement with Mitsubishi Corporation to establish a joint venture partnership for the PAK Lithium Project mine and planned lithium chemicals conversion facility. This joint venture partnership delivers immediate and short-term...

Lead Office: Vancouver Date Closed: -- Value: $25 million

CDPQ on the sale of Plusgrade Inc., alongside Novacap to General Atlantic for more than US$1 billion

Osler advised Caisse de dépôt et placement du Québec (CDPQ) on the sale of Plusgrade Inc., alongside Novacap and certain other shareholders, to General Atlantic for more than US$1 billion. The transaction gives General Atlantic a stake of more than 50 per cent; CDPQ will remain a...

Lead Office: Montreal Date Closed: March 4, 2024 Value: US$1 billion

The agents in connection with First Capital REIT’s offering of $300 million Series B unsecured debentures

On March 1, 2024, First Capital REIT announced the closing of its offering of $300 million aggregate principal amount of Series B senior unsecured debentures on a private placement basis in certain provinces of Canada. The debentures were offered through a syndicate of agents co‐led by Desjardins...

Lead Office: Toronto Date Announced: Mar 1, 2024 Value: $300 million

iCON Infrastructure in its investment in QSL

On February 23, 2024, QSL International Ltd. announced the arrival of new shareholders: funds advised by iCON Infrastructure LLP, CDPQ and the QSL management shareholders already active in the company's capital. QSL is a North American port terminal and logistics operator headquartered in...

Lead Office: Toronto Date Closed: February 23, 2024 Value: -

NOVA Chemicals Corporation in its Offering of US$400 million Senior Secured Notes and its Offering of US$650 million of Senior Unsecured Notes

Osler represented NOVA Chemicals Corporation (“NOVA”) in its 2023 private placement of US$400 million senior secured notes due 2028 (the “2028 Notes”) and its 2024 private placement of US$650 million senior unsecured notes due 2030(the “2030...

Lead Office: Toronto Date Closed: February 5, 2024 Value: US400 million and US$650 million

Mapei in its acquisition of Diaplas

On February 2, 2024, Mapei, through its subsidiary Mapei Canada, announced its acquisition of Diaplas. The acquisition will afford Mapei new opportunities to expand within North America and diversify their current product offerings. Mapei S.p.A. is an Italy-based manufacturer of chemical...

Lead Office: Montreal Date Closed: February 2, 2024 Value: -